Clinical Trial Update: Effect of Ginkgo Biloba Special Extract LI 1370 on Dual-tasking in Patients With MCI [Phase 4]

View source ↗

Summary

Phase 4 clinical trial evaluating the effect of Ginkgo biloba special extract LI 1370 on dual-tasking performance in individuals with mild cognitive impairment …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cognitive Impairment

Drugs mentioned

• Ginkgo biloba special extract LI 1370 (Ginkgo biloba extract LI 1370)

Snippet

Sponsor: University Hospital, Basel, Switzerland | Conditions: Mild Cognitive Impairment | Phase 4 | Status: COMPLETED